Oral Administration of the Broad-Spectrum Antibiofilm Compound Toremifene Inhibits Candida albicans and Staphylococcus aureus Biofilm FormationIn Vivo
2014 ◽
Vol 58
(12)
◽
pp. 7606-7610
◽
Keyword(s):
ABSTRACTWe here report on thein vitroactivity of toremifene to inhibit biofilm formation of different fungal and bacterial pathogens, includingCandida albicans,Candida glabrata,Candida dubliniensis,Candida krusei,Pseudomonas aeruginosa,Staphylococcus aureus, andStaphylococcus epidermidis. We validated thein vivoefficacy of orally administered toremifene againstC. albicans and S. aureusbiofilm formation in a rat subcutaneous catheter model. Combined, our results demonstrate the potential of toremifene as a broad-spectrum oral antibiofilm compound.
2001 ◽
Vol 69
(6)
◽
pp. 4079-4085
◽
2016 ◽
Vol 60
(10)
◽
pp. 5688-5694
◽
2016 ◽
Vol 60
(5)
◽
pp. 3152-3155
◽
Keyword(s):
2015 ◽
Vol 82
(1)
◽
pp. 394-401
◽
Keyword(s):
2015 ◽
Vol 59
(12)
◽
pp. 7308-7315
◽
Keyword(s):